American Bio-optics

Avivo BioOptics’ (ABO) is optimizing the cancer screening process with its InPoint™ System – the first 10min, POC, CLIA-waived, early-stage cancer risk assessment – improving testing compliance and enhancing clinical outcomes by conveniently monitoring average risk patients annually to identify high-risk patients needing follow-on stardard-of-care.